GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targe

GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021

/PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based...

Related Keywords

Switzerland , David Castaneda , Beverly Hills , Exchange Commission , University Of Minnesota , Gt Biopharma Inc , European Society For Medical Oncology , Oncology Io Congress , European Society , Medical Oncology , Poster Display Title , Tri Specific Killer Engager , Annual Report , Quarterly Report , Securities Act , Relations Contacts , Investor Relations Consultant , Gt Biopharma , Nc ,